Cubist Systematic Strategies, LLC Amgen Inc Put Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.18 Million - $1.28 Million	3,800 Added 70.37%	9,200 $2.96 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $236,475 - $287,379	900 Added 20.0%	5,400 $1.69 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $3.25 Million - $3.93 Million	-12,100 Reduced 72.89%	4,500 $1.28 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $2.3 Million - $2.6 Million	-9,000 Reduced 35.16%	16,600 $4.78 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $2.6 Million - $3.23 Million	-11,900 Reduced 31.73%	25,600 $6.88 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.57 Million - $3.04 Million	12,000 Added 47.06%	37,500 $8.33 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.29 Million - $1.57 Million	5,700 Added 28.79%	25,500 $6.16 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $2.73 Million - $3.46 Million	-11,900 Reduced 37.54%	19,800 $5.2 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $2.6 Million - $2.94 Million	11,600 Added 57.71%	31,700 $7.15 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $4.64 Million - $5.16 Million	20,100 New	20,100 $4.89 Million

3,119

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.